Trade deal to boost U.S. demand for Korean generics

Korean generic makers will enjoy a boost in demand from the U.S. market thanks to the free trade agreement sealed between Korea and the United States, experts said.

Korean pharmaceutical firms can win many orders from the United States, because what they charge for designing is about one third of what major U.S. firms charge,'' they said.

The U.S. agreed to set up a cooperative body to m...